Selected research
Market Analysis & Forecast
Global Beta-2 Microglobulin (B2M) Market Analysis and Forecast 2026-2032
Market perspective
The global Beta-2 Microglobulin (B2M) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Beta-2 Microglobulin (B2M) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Beta-2 Microglobulin (B2M) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Beta-2 Microglobulin (B2M) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Beta-2 Microglobulin (B2M) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Beta-2 Microglobulin (B2M) include Wuhan Huamei Biotech Co, Fosun Pharmaceutical, Tosoh, Prospec-Tany Technogene Ltd, Lee Biosolutions, Bio-Rad and Abcam, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Beta-2 Microglobulin (B2M), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Beta-2 Microglobulin (B2M), also provides the sales of main regions and countries. Of the upcoming market potential for Beta-2 Microglobulin (B2M), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Beta-2 Microglobulin (B2M) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Beta-2 Microglobulin (B2M) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Beta-2 Microglobulin (B2M) sales, projected growth trends, production technology, application and end-user industry.
Beta-2 Microglobulin (B2M) Segment by Company
Wuhan Huamei Biotech Co
Fosun Pharmaceutical
Tosoh
Prospec-Tany Technogene Ltd
Lee Biosolutions
Bio-Rad
Abcam
Beta-2 Microglobulin (B2M) Segment by Type
Purity,≥98%
Purity,≥95%
Others
Beta-2 Microglobulin (B2M) Segment by Application
ELISA
Flow Cytometry
Western Blotting
Others
Beta-2 Microglobulin (B2M) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-2 Microglobulin (B2M) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Beta-2 Microglobulin (B2M) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-2 Microglobulin (B2M).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Beta-2 Microglobulin (B2M) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Beta-2 Microglobulin (B2M) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Beta-2 Microglobulin (B2M) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity,≥98%
- Purity,≥95%
- Others
Applications
- ELISA
- Flow Cytometry
- Western Blotting
- Others
Companies covered
- Wuhan Huamei Biotech Co
- Fosun Pharmaceutical
- Tosoh
- Prospec-Tany Technogene Ltd
- Lee Biosolutions
- Bio-Rad
- Abcam
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Beta-2 Microglobulin (B2M) Market by Type
- 1.2.1 Global Beta-2 Microglobulin (B2M) Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Purity,≥98%
- 1.2.3 Purity,≥95%
- 1.2.4 Others
- 1.3 Beta-2 Microglobulin (B2M) Market by Application
- 1.3.1 Global Beta-2 Microglobulin (B2M) Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 ELISA
- 1.3.3 Flow Cytometry
- 1.3.4 Western Blotting
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Beta-2 Microglobulin (B2M) Market Dynamics
- 2.1 Beta-2 Microglobulin (B2M) Industry Trends
- 2.2 Beta-2 Microglobulin (B2M) Industry Drivers
- 2.3 Beta-2 Microglobulin (B2M) Industry Opportunities and Challenges
- 2.4 Beta-2 Microglobulin (B2M) Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Beta-2 Microglobulin (B2M) Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Beta-2 Microglobulin (B2M) Revenue by Region
- 3.2.1 Global Beta-2 Microglobulin (B2M) Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Beta-2 Microglobulin (B2M) Revenue by Region (2021-2026)
- 3.2.3 Global Beta-2 Microglobulin (B2M) Revenue by Region (2027-2032)
- 3.2.4 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Region (2021-2032)
- 3.3 Global Beta-2 Microglobulin (B2M) Sales Estimates and Forecasts 2021-2032
- 3.4 Global Beta-2 Microglobulin (B2M) Sales by Region
- 3.4.1 Global Beta-2 Microglobulin (B2M) Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Beta-2 Microglobulin (B2M) Sales by Region (2021-2026)
- 3.4.3 Global Beta-2 Microglobulin (B2M) Sales by Region (2027-2032)
- 3.4.4 Global Beta-2 Microglobulin (B2M) Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Beta-2 Microglobulin (B2M) Revenue by Manufacturers
- 4.1.1 Global Beta-2 Microglobulin (B2M) Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Beta-2 Microglobulin (B2M) Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Beta-2 Microglobulin (B2M) Sales by Manufacturers
- 4.2.1 Global Beta-2 Microglobulin (B2M) Sales by Manufacturers (2021-2026)
- 4.2.2 Global Beta-2 Microglobulin (B2M) Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Beta-2 Microglobulin (B2M) Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Beta-2 Microglobulin (B2M) Sales Price by Manufacturers (2021-2026)
- 4.4 Global Beta-2 Microglobulin (B2M) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Beta-2 Microglobulin (B2M) Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Beta-2 Microglobulin (B2M) Manufacturers, Product Type & Application
- 4.7 Global Beta-2 Microglobulin (B2M) Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Beta-2 Microglobulin (B2M) Market CR5 and HHI
- 4.8.2 2025 Beta-2 Microglobulin (B2M) Tier 1, Tier 2, and Tier 3
5 Beta-2 Microglobulin (B2M) Market by Type
- 5.1 Global Beta-2 Microglobulin (B2M) Revenue by Type
- 5.1.1 Global Beta-2 Microglobulin (B2M) Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Type (2021-2032)
- 5.2 Global Beta-2 Microglobulin (B2M) Sales by Type
- 5.2.1 Global Beta-2 Microglobulin (B2M) Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Beta-2 Microglobulin (B2M) Sales by Type (2021-2032) & (g)
- 5.2.3 Global Beta-2 Microglobulin (B2M) Sales Market Share by Type (2021-2032)
- 5.3 Global Beta-2 Microglobulin (B2M) Price by Type
6 Beta-2 Microglobulin (B2M) Market by Application
- 6.1 Global Beta-2 Microglobulin (B2M) Revenue by Application
- 6.1.1 Global Beta-2 Microglobulin (B2M) Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Beta-2 Microglobulin (B2M) Revenue Market Share by Application (2021-2032)
- 6.2 Global Beta-2 Microglobulin (B2M) Sales by Application
- 6.2.1 Global Beta-2 Microglobulin (B2M) Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Beta-2 Microglobulin (B2M) Sales by Application (2021-2032) & (g)
- 6.2.3 Global Beta-2 Microglobulin (B2M) Sales Market Share by Application (2021-2032)
- 6.3 Global Beta-2 Microglobulin (B2M) Price by Application
7 Company Profiles
- 7.1 Wuhan Huamei Biotech Co
- 7.1.1 Wuhan Huamei Biotech Co Company Information
- 7.1.2 Wuhan Huamei Biotech Co Business Overview
- 7.1.3 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Product Portfolio
- 7.1.5 Wuhan Huamei Biotech Co Recent Developments
- 7.2 Fosun Pharmaceutical
- 7.2.1 Fosun Pharmaceutical Company Information
- 7.2.2 Fosun Pharmaceutical Business Overview
- 7.2.3 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Product Portfolio
- 7.2.5 Fosun Pharmaceutical Recent Developments
- 7.3 Tosoh
- 7.3.1 Tosoh Company Information
- 7.3.2 Tosoh Business Overview
- 7.3.3 Tosoh Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Tosoh Beta-2 Microglobulin (B2M) Product Portfolio
- 7.3.5 Tosoh Recent Developments
- 7.4 Prospec-Tany Technogene Ltd
- 7.4.1 Prospec-Tany Technogene Ltd Company Information
- 7.4.2 Prospec-Tany Technogene Ltd Business Overview
- 7.4.3 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Product Portfolio
- 7.4.5 Prospec-Tany Technogene Ltd Recent Developments
- 7.5 Lee Biosolutions
- 7.5.1 Lee Biosolutions Company Information
- 7.5.2 Lee Biosolutions Business Overview
- 7.5.3 Lee Biosolutions Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lee Biosolutions Beta-2 Microglobulin (B2M) Product Portfolio
- 7.5.5 Lee Biosolutions Recent Developments
- 7.6 Bio-Rad
- 7.6.1 Bio-Rad Company Information
- 7.6.2 Bio-Rad Business Overview
- 7.6.3 Bio-Rad Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Bio-Rad Beta-2 Microglobulin (B2M) Product Portfolio
- 7.6.5 Bio-Rad Recent Developments
- 7.7 Abcam
- 7.7.1 Abcam Company Information
- 7.7.2 Abcam Business Overview
- 7.7.3 Abcam Beta-2 Microglobulin (B2M) Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Abcam Beta-2 Microglobulin (B2M) Product Portfolio
- 7.7.5 Abcam Recent Developments
8 North America
- 8.1 North America Beta-2 Microglobulin (B2M) Market Size by Type
- 8.1.1 North America Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 8.1.2 North America Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 8.1.3 North America Beta-2 Microglobulin (B2M) Price by Type (2021-2032)
- 8.2 North America Beta-2 Microglobulin (B2M) Market Size by Application
- 8.2.1 North America Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 8.2.2 North America Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 8.2.3 North America Beta-2 Microglobulin (B2M) Price by Application (2021-2032)
- 8.3 North America Beta-2 Microglobulin (B2M) Market Size by Country
- 8.3.1 North America Beta-2 Microglobulin (B2M) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Beta-2 Microglobulin (B2M) Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Beta-2 Microglobulin (B2M) Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Beta-2 Microglobulin (B2M) Market Size by Type
- 9.1.1 Europe Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 9.1.2 Europe Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 9.1.3 Europe Beta-2 Microglobulin (B2M) Price by Type (2021-2032)
- 9.2 Europe Beta-2 Microglobulin (B2M) Market Size by Application
- 9.2.1 Europe Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 9.2.2 Europe Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 9.2.3 Europe Beta-2 Microglobulin (B2M) Price by Application (2021-2032)
- 9.3 Europe Beta-2 Microglobulin (B2M) Market Size by Country
- 9.3.1 Europe Beta-2 Microglobulin (B2M) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Beta-2 Microglobulin (B2M) Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Beta-2 Microglobulin (B2M) Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Beta-2 Microglobulin (B2M) Market Size by Type
- 10.1.1 China Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 10.1.2 China Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 10.1.3 China Beta-2 Microglobulin (B2M) Price by Type (2021-2032)
- 10.2 China Beta-2 Microglobulin (B2M) Market Size by Application
- 10.2.1 China Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 10.2.2 China Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 10.2.3 China Beta-2 Microglobulin (B2M) Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Beta-2 Microglobulin (B2M) Market Size by Type
- 11.1.1 Asia Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 11.1.2 Asia Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 11.1.3 Asia Beta-2 Microglobulin (B2M) Price by Type (2021-2032)
- 11.2 Asia Beta-2 Microglobulin (B2M) Market Size by Application
- 11.2.1 Asia Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 11.2.2 Asia Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 11.2.3 Asia Beta-2 Microglobulin (B2M) Price by Application (2021-2032)
- 11.3 Asia Beta-2 Microglobulin (B2M) Market Size by Country
- 11.3.1 Asia Beta-2 Microglobulin (B2M) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Beta-2 Microglobulin (B2M) Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Beta-2 Microglobulin (B2M) Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Beta-2 Microglobulin (B2M) Market Size by Type
- 12.1.1 SAMEA Beta-2 Microglobulin (B2M) Revenue by Type (2021-2032)
- 12.1.2 SAMEA Beta-2 Microglobulin (B2M) Sales by Type (2021-2032)
- 12.1.3 SAMEA Beta-2 Microglobulin (B2M) Price by Type (2021-2032)
- 12.2 SAMEA Beta-2 Microglobulin (B2M) Market Size by Application
- 12.2.1 SAMEA Beta-2 Microglobulin (B2M) Revenue by Application (2021-2032)
- 12.2.2 SAMEA Beta-2 Microglobulin (B2M) Sales by Application (2021-2032)
- 12.2.3 SAMEA Beta-2 Microglobulin (B2M) Price by Application (2021-2032)
- 12.3 SAMEA Beta-2 Microglobulin (B2M) Market Size by Country
- 12.3.1 SAMEA Beta-2 Microglobulin (B2M) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Beta-2 Microglobulin (B2M) Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Beta-2 Microglobulin (B2M) Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Beta-2 Microglobulin (B2M) Value Chain Analysis
- 13.1.1 Beta-2 Microglobulin (B2M) Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Beta-2 Microglobulin (B2M) Production Mode & Process
- 13.2 Beta-2 Microglobulin (B2M) Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Beta-2 Microglobulin (B2M) Distributors
- 13.2.3 Beta-2 Microglobulin (B2M) Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst